Fat loss: Clinical trials show modest weight loss (~1 kg/month more than placebo) over 8 weeks with doses like 75–150 mg ephedrine, 150–200 mg caffeine, and ~330 mg aspirin daily in divided doses. Sustained use led to further losses over months . Metabolism and energy: Ephedrine stimulates norepinephrine release (raising body temperature and energy expenditure), while caffeine prolongs this effect; aspirin helps extend norepinephrine activity.
GW‑501516 (Cardarine)
Cardarine, also known as GW501516, is associated with several potential benefits that have garnered attention in fitness and wellness circles. Users commonly report increased endurance, attributing it to the compound’s ability to enhance the utilization of fat for energy. This aspect is particularly appealing to athletes and those engaged in cardiovascular activities. Additionally, Cardarine is believed to contribute to improved fat loss by promoting the body’s capacity to burn fat as a primary energy source
L‑Tyrosine
A precursor to dopamine/norepinephrine used to support mental focus and mitigate stress/fatigue
Precautions & Monitoring
Medical oversight: essential—blood pressure, heart rate, ECG recommended. Avoid if: hypertension, cardiovascular disease, diabetes, anxiety disorders, pregnancy/breastfeeding. Cycle breaks: prevent tolerance/dependence; restart only under guidance. Drug interactions: observe use with SSRIs, stimulants, stimulants
Dosage and Cycle
Duration: 4–8 weeks on, followed by a 2–4 week off period to prevent tolerance and reduce health risks. Frequency: 1–2 capsules daily, taken 30–60 minutes before meals/exercise.